Journal of Neuroimmunology
Volume 229, Issue 1 , Pages 112-122 , 15 December 2010

Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice

  • Hua-Xin Gao

      Affiliations

    • The Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY, USA
    • ,
  • Elena Sanders

      Affiliations

    • The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA
    • ,
  • Arlene Tan Tieng

      Affiliations

    • The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA
    • ,
  • Chaim Putterman

      Affiliations

    • The Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY, USA
    • The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA
    • Corresponding Author InformationCorresponding author. Division of Rheumatology, Forchheimer 701N, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY, 10461, USA. Tel.: +1 718 430 4266; fax: +1 718 430 8789.

Received 20 April 2010 ,Revised 15 June 2010 ,Accepted 22 July 2010.

References 

  1. ACR ad hoc committee on neuropsychiatric lupus nomenclature, 1999. American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42, 599-608.
  2. Bluestein HG. The central nervous system in systemic lupus erythematosus. In:  Lahita RG editors. Systemic Lupus Erythematosus. New York: Churchill Livingstone; 1992;p. 639–655
  3. Brey RL, Abbott RD, Curb JD, Sharp DS, Ross GW, Stallworth CL, et al. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke. 2001;32:1701–1706
  4. Dantzer R, Bluthe RM, Koob GF, Le Moal M. Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berl). 1987;91:363–368
  5. De Marcaida JA, Reik L. Disorders that mimic central nervous system infections. Neurol. Clin. 1999;17:901–941
  6. Deocharan B, Zhou Z, Antar K, Siconolfi-Baez L, Angeletti RH, Hardin J, et al. Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J. Immunol. 2007;179:1313–1321
  7. Efthimiou P, Blanco M. Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod. Rheumatol. 2009;19:457–468
  8. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc. Natl Acad. Sci. USA. 1988;85:5186–5189
  9. Elkon KB, Bonfa E, Llovet R, Eisenberg RA. Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J. Immunol. 1989;143:1549–1554
  10. Elkon KB, Parnassa AP, Foster CL. Lupus autoantibodies target ribosomal P proteins. J. Exp. Med. 1985;162:459–471
  11. Ennaceur A, Neave N, Aggleton JP. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp. Brain Res. 1997;113:509–519
  12. Gao HX, Campbell SR, Cui MH, Zong P, Hee-Hwang J, Gulinello M, et al. Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J. Neuroimmunol. 2009;207:45–56
  13. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke. 2002;33:862–875
  14. Hermosillo-Romo D, Brey RL. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract. Res. Clin. Rheumatol. 2002;16:229–244
  15. Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 2007;56:938–948
  16. Kiss E, Shoenfeld Y. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?. Clin. Rev. Allergy Immunol. 2007;32:37–46
  17. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl Acad. Sci. USA. 2006;103:19854–19859
  18. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity; antibody impairs memory. Immunity. 2004;21:179–188
  19. Matus S, Burgos PV, Bravo-Zehnder M, Kraft R, Porras OH, Farias P, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J. Exp. Med. 2007;204:3221–3234
  20. Moscavitch SM, Szyper-Kravitz M, Shoenfeld Y. Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: The olfactory and immune system interrelationship. Clin. Immunol. 2009;130:235–243
  21. Muscal E, Myones BL. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun. Rev. 2007;6:215–217
  22. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14:149–167
  23. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J. Autoimmun. 2000;15:145–151
  24. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Thér. 1977;229:327–336
  25. Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. 1998;188:29–38
  26. Reichlin M. Autoantibodies to ribosomal P proteins in SLE. Clin. Exp. Med. 2006;6:49–52
  27. Rivest C, Lew RA, Welsing PM, Sangha O, Wright EA, Roberts WN, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J. Rheumatol. 2000;27:680–684
  28. Sakic B, Denburg JA, Denburg SD, Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res. Bull. 1996;41:305–311
  29. Sakic B, Szechtman H, Denburg S, Carbotte R, Denburg JA. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice. Physiol. Behav. 1993;54:1025–1029
  30. Sakic B, Szechtman H, Denburg SD, Denburg JA. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiol. Behav. 1995;58:797–802
  31. Sakic B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav. Immun. 1992;6:265–285
  32. Sakic B, Szechtman H, Talangbayan H, Denburg S, Carbotte R, Denburg JA. Behavior and immune status of MRL mice in the postweaning period. Brain Behav. Immun. 1994;8:1–13
  33. Sakic B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 1994;56:609–617
  34. Schrott LM, Crnic LS. Increased anxiety behaviors in autoimmune mice. Behav. Neurosci. 1996;110:492–502
  35. Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, Paran D, Katz BS, Kivity S, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60:1484–1487
  36. Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus. 2003;12:436–442
  37. Sibbitt WL, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999;42:2026–2038
  38. Sidor MM, Sakic B, Malinowski PM, Ballok DA, Oleschuk CJ, Macri J. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J. Neuroimmunol. 2005;165:104–113
  39. Stojanovich L, Zandman-Goddard G, Pavlovich S, Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun. Rev. 2007;6:421–426
  40. Toubi E, Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun. Rev. 2007;6:119–125
  41. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, et al Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am. J. Med. 1994;96:3–9
  42. Vogelweid CM, Johnson GC, Besch-Williford CL, Basler J, Walker SE. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 1991;35:89–99
  43. Zandman-Goddard G, Chapman J, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 2007;36:297–315
  44. Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest. 1997;100:613–619

PII: S0165-5728(10)00333-4

doi: 10.1016/j.jneuroim.2010.07.020

Journal of Neuroimmunology
Volume 229, Issue 1 , Pages 112-122 , 15 December 2010

Article Tools

* Image Usage & Resolution